The scale-up, promotion and use of oral pre-exposure prophylaxis (PrEP) in different settings and in different populations.

PrEP programmes and uptake: latest news

PrEP programmes and uptake resources

  • How to get PrEP in the UK

    In England, PrEP is available to people taking part in the PrEP Impact trial.In Wales, Scotland and Northern Ireland, PrEP is available through NHS sexual health clinics.It...

    From: Factsheets

    Information level Level 2

PrEP programmes and uptake news from aidsmap

More news

PrEP programmes and uptake news selected from other sources

  • Council chiefs welcome decision to expand PrEP trial

    Local authority leaders have said they are 'pleased' with NHS England's decision to expand the trial of a drug that could 'significantly' reduce levels of HIV.

    15 January 2019 | LocalGov
  • NHS hope to double capacity of PrEP trial after huge demand for HIV prevention drug

    Deborah Gold, Chief Executive of NAT (National AIDS Trust), said: “Having been pushing for increased access to PrEP for so long, we are pleased that NHS England has listened to us and agreed to fund more spaces for PrEP patients on the Impact trial. It has been completely unacceptable to see people in need of PrEP being turned away from clinics."

    11 January 2019 | National AIDS Trust
  • NHS England announces support for doubling PrEP trial

    NHS England announced on Friday (11 January) its support for a request from researchers leading the PrEP IMPACT Trial. The request asks for the trial to double its places. This would give 26,000 people access to the life-saving pill, compared to the former 13,000 people.

    11 January 2019 | Gay Star News
  • PrEP: Postcode lottery of anti-HIV drug trial

    A game-changer in the fight against HIV, pre-exposure prophylaxis (PrEP) is a highly effective drug that reduces the risk of acquiring the condition. But as the NHS trials PrEP across England, many at high risk have struggled to get hold of the drug.

    11 January 2019 | BBC News
  • Hep C Infection May Be on the Rise Among Men Using PrEP

    The incidence of sexually acquired hepatitis C virus (HCV) infections appears to be rising among men who have sex with men (MSM) and use pre-exposure prophylaxis (PrEP) against HIV, U.S. researchers report.

    09 January 2019 | Medscape (requires free registration)
  • PrEP home delivery study brings PrEP to young men of color

    The small group of young men who took part in a recent PrEP study by a group of California researchers liked being able to access PrEP services and care from the comfort of their own home. The study, called PrEPTECH, offered “telehealth” PrEP care—with clinical visits through a video-based app, home STI testing, and PrEP medication delivered to their doorstep.

    08 January 2019 | BETA blog
  • Top 10 HIV Clinical Developments of 2018

    It's the beginning of the end. Not in some apocalyptic way, but rather in how we think about the prevention and management of HIV.

    20 December 2018 | The Body Pro
  • Can PrEP on Demand for HIV Prevention Work in the U.S.? Experts Answer Your Questions

    The efficacy of on-demand PrEP is uncontroversial, but work is still needed to inform clinicians, PrEP programs, and other HIV programs serving communities of color in the U.S. This was the central theme of a panel discussion about on-demand PrEP at the recent December 3-4 Biomedical HIV Prevention Summit, held December 3 and 4 in Los Angeles.

    17 December 2018 | The Body Pro
  • Councils call for major extension of national HIV prevention trial

    The Association of Directors of Public Health (ADPH) and Local Government Association (LGA) are calling for a major extension of access to PrEP to help end the epidemic of HIV in the UK. ADPH and LGA fully support PrEP as part of an effective HIV prevention strategy, with the potential to save lives. Our only concern is the unfunded cost to councils as a result of rolling PrEP out, whether as part of expanding the number of people on the PrEP Trial or in a future national HIV PrEP programme. We are calling for the forthcoming NHS long-term plan to commit to fully fund expanded access to the HIV PrEP Trial ensuring that both unresolved implementation questions are addressed and that local authority sexual health services are adequately resourced to support this extension.

    14 December 2018 | The Association of Directors of Public Health
  • Drug buyers' clubs aim to tackle HIV prevention 'crisis'

    A new generation of drug buyers' clubs like those set up at the height of the AIDS epidemic is seeking to combat a "crisis" in preventing new HIV infections by providing access to cheap generics of a breakthrough prophylactic.

    12 December 2018 | Medscape
More news
Tell us why you visited aidsmap today

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?


Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.